mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.4 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.4 |